Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Journal of Clinical Psychopharmacology|June 23, 2012
Reduced methadone clearance during aromatase inhibitionWenjie Jessie Lu, Nancy Thong, David A FlockhartAntimicrobial Agents and Chemotherapy|November 2, 2016
Population Pharmacokinetic Modeling To Estimate the Contributions of Genetic and Nongenetic Factors to Efavirenz DispositionJason D Robarge, Ingrid F Metzger, Jessica Lu, et al.Journal of Clinical Gastroenterology|October 22, 2010
Drug-induced QT prolongation in cirrhotic patients with transjugular intrahepatic portosystemic shuntRaj Vuppalanchi, Ravi Juluri, Marwan Ghabril, et al.Antimicrobial Agents and Chemotherapy|September 8, 2016
Inhibition of Cytochrome P450 2B6 Activity by Voriconazole Profiled Using Efavirenz Disposition in Healthy VolunteersZeruesenay Desta, Ingrid F Metzger, Nancy Thong, et al.Journal of Cardiovascular Electrophysiology|June 24, 2016
Efavirenz Inhibits the Human Ether-A-Go-Go Related Current (hERG) and Induces QT Interval Prolongation in CYP2B6*6*6 Allele CarriersAhmed M Abdelhady, Tyler Shugg, Nancy Thong, et al.Current Therapeutic Research, Clinical and Experimental|October 30, 2014
Substantial effect of efavirenz monotherapy on bilirubin levels in healthy volunteersIngrid F Metzger, Troy C Quigg, Noam Epstein, et al.Clinical Pharmacology and Therapeutics|September 30, 2017
Variants in the CYP2B6 3'UTR Alter In Vitro and In Vivo CYP2B6 Activity: Potential Role of MicroRNAsKimberly S Burgess, Joseph Ipe, Marelize Swart, et al.Pageof 1